NCT05523440
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05523440
Title Bevacizumab and/or Niraparib in Patients With Recurrent Endometrial and/or Ovarian Cancer With ARID1A Mutation
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors University of Oklahoma
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Oklahoma Health Sciences Center, Stephenson Cancer Center Oklahoma City Oklahoma 73104 United States Details
University of Virginia Comprehensive Cancer Center Charlottesville Virginia 22903 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field